CABAZITAXEL PACKAGE INSERT EPUB
17 Mar One ml of concentrate contains 40 mg cabazitaxel. The printed package leaflet of the medicinal product must state the name and address of. See JEVTANA 20 mg/m² recommended dosing and dose modifications (every 3 weeks with prednisone 10 mg daily). 25 mg/m² can be considered in select. Package leaflet: Information for the patient. JEVTANA® 60 mg concentrate and solvent for solution for infusion. cabazitaxel. Read all of this leaflet carefully.
|Published (Last):||23 June 2017|
|PDF File Size:||20.28 Mb|
|ePub File Size:||3.43 Mb|
|Price:||Free* [*Free Regsitration Required]|
If this happens, do not drive or use any tools or machines until you feel better. Do not take any new medicines without asking your HCP cabazitaxel package insert. Enter medicine name or company Start typing to retrieve search suggestions. See a doctor immediately if you notice any of the following side effects: Contents of the pack and other information. Monitor for cystitis packae patients who previously received pelvic radiation; cabazitaxel package insert or discontinue if severe hemorrhagic cystitis occurs.
Monitor closely for respiratory disorders; interrupt if new or worsening pulmonary symptoms develop. Febrile neutropenia or neutropenic infection.
JEVTANA can cause cabazitaxel package insert leak in the stomach or intestine, intestinal blockage, infection, and bleeding in the stomach or intestine. This medicine may be harmful for those suffering from alcoholism. The active substance is cabazitaxel.
Any of these events could cause severe dehydration. Uncommon may affect up to 1 in people: Cabazitaxel package insert prior radiation ports Poor nutritional status Other serious comorbidities.
If you have any further questions, ask your doctor, pharmacist or nurse. One single use clear glass vial, closed with a grey chlorobutyl rubber closure sealed by a gold colour aluminium cap with a colourless plastic flip-off cover, containing 4. Severe vomiting and diarrhea with JEVTANA can lead to loss of too much body fluid dehydrationor too much of your body salts electrolytes.
By reporting cabazitaxel package insert effects you can help provide more information on the cabazitaxel package insert of this medicine. Increased risk of neutropenia complications; consider G-CSF prophylaxis recommended in high risk patients.
Your doctor will calculate your body surface area in square meters m 2 and will decide the dose you should have. Allergy to polysorbate Kidney failure may happen with JEVTANA, because of severe cabazitaxel package insert, loss of too much body fluid dehydrationand other reasons, which may lead to death.
imsert Call your doctor for medical advice about side effects. Your HCP will check you for this problem and cabazitaxel package insert you if needed.
This is very common may affect more than 1 in 10 people. You are about to packkage jevtanapro. Sanofi Genzyme’s privacy procedures do not cabazitaxel package insert to the owners of a non-Sanofi Genzyme website.
Possible side effects Like all medicines, this medicine can cause side effects, although not everybody gets them. Your HCP may prescribe treatment for you as needed. You may need to read it again. Older cabazitaxel package insert Poor performance status Previous episodes of febrile neutropenia. To be taken into account if you are in a high risk group such as patients with liver disease, or epilepsy. Please tell your doctor, pharmacist or nurse if you are taking or have recently taken any other medicines.
May be antagonized by rifampin. You can also report side effects directly via the contact details listed below. Driving and using machines You may feel tired or dizzy when having inseft medicine.
European Medicines Agency – System/website unavailable
Healthcare Professionals Only Sanofi Genzyme. The expiry cabazitaxel package insert refers to the last day of that month. JEVTANA is contraindicated in patients who have a history of severe hypersensitivity reactions to cabazitaxel or to other drugs formulated with polysorbate These medicines include the following: